These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19229632)

  • 1. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic and novel roles of p53: prospects for anticancer therapy.
    Fuster JJ; Sanz-González SM; Moll UM; Andrés V
    Trends Mol Med; 2007 May; 13(5):192-9. PubMed ID: 17383232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with p53, dying of p53.
    Aylon Y; Oren M
    Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment.
    Tzatsos A; Papavassiliou AG
    Anticancer Res; 1999; 19(5B):4353-6. PubMed ID: 10628400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS; Kung AL
    Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis.
    Amaral JD; Castro RE; Steer CJ; Rodrigues CM
    Trends Mol Med; 2009 Nov; 15(11):531-41. PubMed ID: 19822456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of p53 in apoptosis.
    Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
    Discov Med; 2010 Feb; 9(45):145-52. PubMed ID: 20193641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
    Kim E; Giese A; Deppert W
    Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
    Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of p53 activation--spoilt for choice.
    Vousden KH
    J Cell Sci; 2006 Dec; 119(Pt 24):5015-20. PubMed ID: 17158908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.
    Bremer E; Helfrich W
    Discov Med; 2006 Jun; 6(33):113-7. PubMed ID: 17234145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53--a natural cancer killer: structural insights and therapeutic concepts.
    Römer L; Klein C; Dehner A; Kessler H; Buchner J
    Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting p53 for enhanced radio- and chemo-sensitivity.
    Lu C; El-Deiry WS
    Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional basis for therapeutic modulation of p53 signaling.
    Bassett EA; Wang W; Rastinejad F; El-Deiry WS
    Clin Cancer Res; 2008 Oct; 14(20):6376-86. PubMed ID: 18927276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can loss of apoptosis protect against cancer?
    Wodarz D; Komarova N
    Trends Genet; 2007 May; 23(5):232-7. PubMed ID: 17382429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
    Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
    Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncoapoptosis: a novel molecular therapeutic for cancer treatment.
    Blaho JA
    IUBMB Life; 2010 Feb; 62(2):87-91. PubMed ID: 19937971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.